COMP <GO>
ENSG vs ABBV // FREE CASH FLOW YIELD
The Ensign Group Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: ENSG 5
— ABBV 10
▲ FREE CASH FLOW YIELD LEADER: ABBV
LAST: $181.52 (-2.58%) • MKT CAP: $10.87B
fcf-yield
3.11%
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
fcf-yield
3.47%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ENSG VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ENSG | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.10% | 70.20% | -50.10 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.00% | 29.00% | -11.00 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 33.3x | -16.30 | ENSG | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 3.11% | 3.47% | -0.36 | ABBV | /fcf-yield <GO> |
| Operating Margin | 8.50% | 24.60% | -16.10 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 6.80% | 6.90% | -0.10 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 18.80% | 8.60% | +10.20 | ENSG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.13% | 2.27% | -2.14 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.73 | 5.33 | -1.60 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ENSG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 7.40% | -0.90 | ENSG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.9 | 72.8 | -16.84 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 1.15 | -0.26 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.5x | 113.1x | -86.60 | ENSG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.87B | $513.86B | -$502.99B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ENSG REV | ABBV REV | ENSG GROSS % | ABBV GROSS % | ENSG FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.03B | $61.16B | 20.1% | 70.2% | $337.8M | $17.82B |
| FY 2024 | $4.24B | $56.33B | 20.3% | 70.0% | $156.5M | $17.83B |
| FY 2023 | $3.71B | $54.32B | 44.0% | 44.0% | $209.8M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ENSG // BETA 0.89
ABBV // BETA 1.15